☆ 4.3 Article

A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine((R))) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

LEUKEMIA RESEARCH (2008)

主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。

Discuss science. Find collaborators. Network.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started